EPIRUS Biopharmaceuticals

40 articles about EPIRUS Biopharmaceuticals

• EPIRUS Biopharma COO Still Sees Promise for Biosimilars Despite Setback

  5/12/2016

• EPIRUS Biopharma to Slash 40% of Workforce, Suspend Lead Clinical Program and Replaces CEO

  5/11/2016

• Arena Names EPIRUS Biopharma's Amit D. Munshi as New CEO

  5/10/2016

• EPIRUS Biopharmaceuticals Reports Fourth Quarter And Fiscal Year 2015 Financial Results And Provides Business Update

  3/15/2016

• EPIRUS Biopharmaceuticals To Release Fourth Quarter And Fiscal Year 2015 Financial Results And Provide Business Update

  3/1/2016

• EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase III Clinical Study For BOW015 (Infliximab Biosimilar)

  2/9/2016

• EPIRUS Biopharmaceuticals To Participate In Bloomberg Intelligence Healthcare Event On February 12

  2/8/2016

• EPIRUS Biopharmaceuticals To Present At LEERINK Partners 5th Annual Global Healthcare Conference

  2/3/2016

• EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business Update

  11/16/2015

• EPIRUS Biopharmaceuticals Provides Clinical Program Update On BOW015 (Infliximab Biosimilar)

  11/16/2015

• EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Results Conference Call And Webcast

  11/12/2015

• EPIRUS Biopharmaceuticals Appoints Industry Veteran Vincent E. Aurentz As Chief Business Officer

  11/10/2015

• EPIRUS Biopharmaceuticals Joins Biosimilars Forum To Help Educate Patients And Healthcare Providers On Importance Of Biosimilars

  11/5/2015

• EPIRUS Biopharmaceuticals To Release Third Quarter 2015 Financial Results And Provide Business Update

  10/29/2015

• EPIRUS Biopharmaceuticals Expands Biosimilar Pipeline And Capabilities Through Acquisition Of Bioceros

  9/9/2015

• EPIRUS Biopharmaceuticals And Polpharma SA Enter Into A Multi-Product, Multi-Region, Profit-Sharing Collaboration To Advance Biosimilar Portfolio Targeting $6 Billion Addressable Innovator Market

  7/14/2015

• EPIRUS Biopharmaceuticals Presents New BOW015 (Infliximab Biosimilar) Data At The European League Against Rheumatism Annual Congress (EULAR 2015)

  6/10/2015

• EPIRUS Biopharmaceuticals Reports First Quarter 2015 Financial Results

  5/12/2015

• EPIRUS Biopharmaceuticals To Present At Bank of America Merrill Lynch 2015 Healthcare Conference

  5/7/2015

• EPIRUS Biopharmaceuticals To Host Biosimilar Key Opinion Leader Meeting And Webcast On March 30

  3/25/2015